Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange

EXtend and eXjange were prospective, 1-yr, non-interventional, observational, multicentre studies that investigated deferasirox, a once-daily oral iron chelator, in iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes (MDS), respectively, treated in the daily-routi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gattermann, Norbert, Jarisch, Andrea, Schlag, Rudolf, Blumenstengel, Klaus, Goebeler, Mariele, Groschek, Matthias, Losem, Christoph, Procaccianti, Maria, Junkes, Alexia, Leismann, Oliver, Germing, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505370/
https://www.ncbi.nlm.nih.gov/pubmed/22023452
http://dx.doi.org/10.1111/j.1600-0609.2011.01726.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505370/
https://www.ncbi.nlm.nih.gov/pubmed/22023452
http://dx.doi.org/10.1111/j.1600-0609.2011.01726.x

Ejemplares similares